D.A. Davidson & Co’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-2,310
Closed -$225K 1048
2020
Q3
$225K Sell
2,310
-982
-30% -$113K ﹤0.01% 845
2020
Q2
$404K Sell
3,292
-1,958
-37% -$222K 0.01% 674
2020
Q1
$460K Sell
5,250
-246
-4% -$26.1K 0.01% 610
2019
Q4
$575K Buy
5,496
+1,472
+37% +$165K 0.01% 651
2019
Q3
$463K Buy
4,024
+413
+11% +$62.7K 0.01% 674
2019
Q2
$623K Buy
3,611
+117
+3% +$20.2K 0.01% 587
2019
Q1
$589K Buy
+3,494
New +$520K 0.01% 643
2018
Q4
Sell
-1,801
Closed -$311K 1191
2018
Q3
$311K Buy
+1,801
New +$260K 0.01% 898
2017
Q3
Sell
-100
Closed -$10K 2154
2017
Q2
$10K Hold
100
﹤0.01% 2053
2017
Q1
$12K Hold
100
﹤0.01% 1986
2016
Q4
$11K Hold
100
﹤0.01% 2102
2016
Q3
$13K Sell
100
-48
-32% -$4.59K ﹤0.01% 1987
2016
Q2
$13K Buy
148
+48
+48% +$4.04K ﹤0.01% 1904
2016
Q1
$7K Hold
100
﹤0.01% 1992
2015
Q4
$6K Hold
100
﹤0.01% 2006
2015
Q3
$9K Hold
100
﹤0.01% 1890
2015
Q2
$12K Hold
100
﹤0.01% 1837
2015
Q1
$9K Buy
+100
New +$8.12K ﹤0.01% 1829

Other funds holding GWPH

D.A. Davidson & Co's GWPH Position: Q4 2020 in Review

D.A. Davidson & Co sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2020, closing a stake of 2,310 shares — an estimated $225K sold.

D.A. Davidson & Co first reported a position in GWPH in Q1 2015 and held it in 18 quarters. The position peaked at $623K in Q2 2019. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

  • D.A. Davidson & Co reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • D.A. Davidson & Co sold 2,310 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2020, an estimated $225K.
  • D.A. Davidson & Co first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2015 and held it in 18 quarters.
  • D.A. Davidson & Co's GW Pharmaceuticals Plc American Depositary Shares position peaked at $623K in Q2 2019.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on D.A. Davidson & Co's 13F filing for Q4 2020, filed 10 Feb 2021.